Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 6/20 | 0.33 |
| ▸ | CA1 | P00915 | 5/20 | 0.33 |
| ▸ | MMP1 | P03956 | 4/20 | 0.33 |
| ▸ | MMP2 | P08253 | 4/20 | 0.33 |
| ▸ | MMP9 | P14780 | 4/20 | 0.33 |
| ▸ | MMP8 | P22894 | 4/20 | 0.33 |
| ▸ | MMP13 | P45452 | 4/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | F2 | P00734 | 1/20 | 0.30 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.30 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.30 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5336890 | 1.00 | THRB (0.56) | THRBALDH1A1TSHRCA2CA1 | |
| SCHEMBL1790510 | 1.00 | THRB (0.56) | THRBALDH1A1TSHRCA2CA1 | |
| SCHEMBL5337470 | 1.00 | THRB (0.56) | THRBALDH1A1TSHRCA2CA1 | |
| SCHEMBL28371881 | 0.89 | THRB (0.48) | THRBALDH1A1TSHRCA2CA1 | |
| SCHEMBL28925386 | 0.79 | THRB (0.56) | THRBALDH1A1TSHRCA2CA1 | |
| SCHEMBL1790667 | 0.77 | ALDH1A1 (0.44) | THRBALDH1A1TSHRLMNA | |
| Acetic Acid SCHEMBL28332245 | 0.77 | THRB (0.60) | THRBALDH1A1TSHRCA2CA1 | |
| SCHEMBL28293544 | 0.77 | THRB (0.68) | THRBALDH1A1TSHRCA2CA1 | |
| Fluoride SCHEMBL10825823 | 0.77 | THRB (0.37) | THRBALDH1A1TSHR | |
| SCHEMBL26348102 | 0.77 | THRB (0.54) | THRBALDH1A1TSHRCA2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8106222-B2 | Fluorine-containing ether compound | FUJIFILM CORPORATION (JP) | 2012-01-31 | — | — | US | disclosed |
| US-20090018350-A1 | NOVEL FLUORINE-CONTAINING ETHER COMPOUND | FUJIFILM CORPORATION (JP) | 2009-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090018350-A1 | NOVEL FLUORINE-CONTAINING ETHER COMPOUND | AFF4, AFF1, AFF2 | THRB 2210/4885ALDH1A1 3233/4885TSHR 530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.